Mon, Dec 29, 2014, 10:04 AM EST - U.S. Markets close in 5 hrs 56 mins

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • tonytiger706 tonytiger706 Aug 20, 2014 8:26 AM Flag

    Any idea when the secondary will be filled

    so snta can fill the coffers and move forward with fda approval of ganetespib? Any known time frame for a NDA review? I know...call me lazy...lol!

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What do you think they are doing with these open At-The-Money Offerings???

      All of the clinical information can be found on the website. There is an August 2014 corporate presentation link on their landing page. By year end, I believe Synta will have new messaging and branding to support ganetespib by virtue of them retaining the Navicor Group in April.

      My guess is the Company will have somewhere around $120 million on the balance sheet by the time we get to the next quarterly call (in November), providing them a runway into 1H2016 (which can obviously be extended should they sign a distribution deal taking a chunk of the cash upfront).

      Oh, and yes, don't be lazy. It's your money...get on it.

      Sentiment: Buy

 
SNTA
2.6701+0.0601(+2.30%)10:04 AMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.